We have observed
3 EP applications
Alain Henri Werner
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 14, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
1,3,5 -TRIAZINE-2-AMINE DERIVATIVES, PREPARATION THEREOF AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF
Use of rifapentine in the treatment and/or prevention of active tuberculosis disease
MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF